Cassiopea SpA has launched Winlevi® for acne vulgaris treatment market 2021

Acne vulgaris treatment is vital to keep skin clear and healthy. This type of acne affects almost everyone at some point in their life. Acne vulgaris treatment is also essential because of the long-term health effects that can result from this type of skin disease. Acne vulgaris is a serious skin disease that happens when oil and dead skin cells from skin clog pores and cause inflammation. Common symptoms of this condition include whiteheads or blackheads, inflamed skin, acne scars, acne, and possible scarring to face. Some of the Major Companies covered in this Research are Allergan plc, GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.

Request Here Sample + 360 Pages PDF, All Related Graphs of this Report @: https://www.coherentmarketinsights.com/insight/request-sample/1260

Growing awareness regarding acne in teenagers coupled with the rise in disposable income is augmenting the growth of the acne vulgaris treatment market. Manufacturers are focussing on introducing effective treatments for acne vulgaris which is also uplifting the growth of the market. In September 2020, Alembic Pharmaceuticals announces the launch of their bioequivalent and therapeutically equivalent product to Differin Gel 0.3% (Galderma), Adapalene Gel USP 0.3%, a topical retinoid for the treatment of acne vulgaris in patients 12 years and older. Also, in August 2020, the U.S. Food and Drug Administration (FDA) approved Italy-based Cassiopea SpA’s acne treatment Winlevi (clascoterone cream 1%). Winlevi is the first acne drug with a new mechanism of action to win regulatory approval in the United States.

1. In December 2019, Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, the prescription dermatology health care businesses announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for ARAZLOTM (tazarotene) Lotion, 0.045%, for the topical treatment of acne vulgaris in patients nine years of age and older.

2. In August 2020, Cassiopea SpA announced that the United States Food and Drug Administration (FDA) approved Winlevi® (clascoterone cream 1%) for the treatment of acne in patients 12 years and older

3. In December 2020, Sol-Gel Technologies, Ltd. launched New Drug Application (NDA) for Twyneo® (benzoyl peroxide and tretinoin), an investigational proprietary fixed-dose combination of 3% encapsulated benzoyl peroxide and 0.1% encapsulated tretinoin cream for the treatment of acne vulgaris

Get Discount On The Purchase Of This Report @
https://www.coherentmarketinsights.com/promo/buynow/1260
Table of Contents

-- Report Overview: It includes the Acne Vulgaris Treatment market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

-- Executive Summary: This section of the report gives information about Acne Vulgaris Treatment market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

-- Profiles of International Players: Here, key players of the Acne Vulgaris Treatment market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

-- Regional Study: All of the regions and countries analyzed in the Acne Vulgaris Treatment market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Inquire more about this report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1260

Key Benefits:

• This study gives a detailed analysis of drivers and factors limiting the market expansion of Acne Vulgaris Treatment

• The micro-level analysis is conducted based on its product types, end-user applications, and geographies

• Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

• By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Acne Vulgaris Treatment market

The research study can answer the following Key questions:

• What will be the progress rate of the Acne Vulgaris Treatment Market for the conjecture period, 2021-2028?

• What are the prominent factors driving the Acne Vulgaris Treatment Market across different regions?

• Who are the major vendors dominating the Acne Vulgaris Treatment industry and what are their winning strategies?

• What will be the market scope for the estimated period?

• What are the major trends shaping the expansion of the industry in the coming years?

• What are the challenges faced by the Acne Vulgaris Treatment Market?

Read Detailed Index of Full Research Study at @
https://www.coherentmarketinsights.com/ongoing-insight/acne-vulgaris-treatment-market-1260

Our analysts are experts in this field with years of experience. We at Coherent Market Insights maintain the highest level of accuracy and transparency in the report. The primary and secondary resources used in the report are taken from reliable and high authority sources to deliver 100% accurate and trusted data.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Oceania, LATAM, South America, NORDIC, West Europe, Europe or Southeast Asia.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Author:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunities.

This release was published on openPR.